Surgical innovations in the treatment of benign prostatic hyperplasia: Towards new standard treatments?;Innovations chirurgicales dans le traitement de l'Hyperplasie Bénigne de la Prostate: Vers de nouveaux standards thérapeutiques?

Progres en Urologie

Volumn 17, Issue 5 SUPPL. 1, 2007, Pages 1026-1028

  Cornu, Jean Nicolas ^a   Rouprêt, Morgan ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

(MeSH): prostate; Benign prostatic hyperplasia; Laser; TURP

Indexed keywords

ARTICLE; HUMAN; MALE; METHODOLOGY; PROSTATE HYPERTROPHY; PROSTATECTOMY; TREATMENT FAILURE; URETHRA;

HUMANS; MALE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; TREATMENT FAILURE; URETHRA;

EID: 35348849417     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. PORPIGLIA F, TERRONE C, RENARD J, GRANDE S, MUSSO F, COSSU M, et al. Transcapsular adenomectomy (Millin): a comparative study, extraperitoneal laparoscopy versus open surgery. Eur Urol, 2006; 49: 120-6.
2. VAN VELTHOVEN R, PELTIER A, LAGUNA MP, PIECHAUD T. Laparoscopic extraperitoneal adenomectomy (Millin): pilot study on feasibility. Eur Urol, 2004; 45: 103-9.
3. COEURDACIER P, STAERMAN F, CORBEL L, CIPOLLA B, GUILLE F, LOBEL B. Peut-on mieux faire que la chirurgie dans le traitment de l'hypertrophie bénigne de prostate? Les résultats à 10 ans de la résection endoscopique et de l'adénomectomie sur les troubles mictionnels et la sexualité. Prog Urol, 1993; 3: 1016-23.
4. MADERSBACHER S, ALIVIZATOS G, NORDLING J, SANZ CR, EMBERTON M, DE LA ROSETTE JJ. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol, 2004; 46: 547-54.
5. IRANI J, BROWN CT, VAN DER MEULEN J, EMBERTON M. A review of guidelines on benign prostatic hyperplasia and lower urinary tract symptoms: are all guidelines the same? BJU Int, 2003; 92: 937-42.
6. JANIN P, HAILLOT O, BOUTIN JM, LESOURD B, HUBERT B, LANSON Y. Fréquence de la chirurgie de l'hypertrophie bénigne de la prostate. Prog Urol, 1995; 5:515-21.
7. AHYAI SA, LEHRICH K, KUNTZ RM. Holmium Laser Enucleation versus Transurethral Resection of the Prostate: 3-Year Follow-Up Results of a Randomized Clinical Trial. Eur Urol, 2007, in press.
8. WILSON LC, GILLING PJ, WILLIAMS A, KENNETT KM, FRAMPTON CM, WESTENBERG AM, et al. A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol, 2006; 50: 569-73.
9. KUNTZ RM, LEHRICH K. Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm.: a randomized prospective trial of 120 patients. J Urol, 2002; 168: 1465-9.
10. PELTIER A, HOFFMAN R HAWAUX E, ENTERAZI K, DENEFT F, VAN VELTHOVEN R. Laparoscopic extraperitoneal millin's adenomectomy versus open retropubic adenomectomy: a prospective comparison. Eur Urol Supplements, 2007; 6: 163.
11. GOMELLA LG, LOTFI MA, RIVAS DA, CHANCELLOR MB. Contact laser vaporization techniques for benign prostatic hyperplasia. J Endourol, 1995; 9: 117-23.
12. TUHKANEN K, HEINO A, AALTOMAA S, ALA-OPAS M. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates. Scand J Urol Nephrol, 2003; 37: 487-93.
13. RUSZAT R, WYLER S, FORSTER T, REICH O, STIEF CG, GASSER TC, et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol, 2007; 51: 1031-8; discussion 1038-41.
14. BACHMANN A, SCHURCH L, RUSZAT R, WYLER SF, SEIFERT HH, MULLER A, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol, 2005; 48: 965-72.
15. FRIED NM. New laser treatment approaches for benign prostatic hyperplasia. Curr Urol Rep, 2007; 8: 47-52.
16. BACHMANN A, RUSZAT R. Greenlight laser vaporization or conventional electroresection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. Schweiz Rundsch Med Prax, 2007; 96: 61-7.
17. RUSZAT R, WYLER S, FORSTER T, SULSER T, BACHMANN A. Complications of photoselective vaporization of the prostate. Eur Urol Supplements, 2007; 6: 136.
18. BACH T, HERRMANN TR, GANZER R, BURCHARDT M, GROSS AJ. RevoLixtrade mark vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol, 2007; 25: 257-62.
19. SARICA K, ALKAN E, LULECI H, TASCI AI. Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients. J Endourol, 2005; 19: 1199-202.
20. CIMENTEPE E, UNSAL A, SAGLAM R. Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18 months. J Endourol, 2003; 17: 103-7.
21. HILL B, BELVILLE W, BRUSKEWITZ R, ISSA M, PEREZ-MARRERO R, ROEHRBORN C, et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol, 2004; 171: 2336-40.
22. DESGRANDCHAMPS F, DE LA TAILLE A, DOUBLET JD. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia. BJU Int, 2006; 97: 727-33.
23. LUKACS B. Management of symptomatic BPH in France: who is treated and how? Eur Urol, 1999; 36 Suppl 3: 14-20.